EBS News and Press, Emergent Biosolutions Inc. From 12/18/23

2023-12-18 02:51:34 ET Summary Emergent BioSolutions stock has a call option-like structure to it and trades as an equity stub currently behind a high debt load. However, business performance may be improving into the important Q4 period, with results coming in February 2024. ...

2023-12-14 10:00:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Ocular Therape...

2023-12-12 08:07:31 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Icosavax (NASDAQ: ICVX ) stock is rising higher on Tuesday after announcing a major acquisition deal with AstraZeneca (NASDAQ: AZN ). According to a press release, A...

2023-12-12 06:53:32 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Emergent BioSolutions (NYSE: EBS ) just reported results for the third quarter of 2023. Emergent BioSolutions reported earnings per share of -87 cents. This was below the ...

2023-11-28 07:14:33 ET More on Emergent Biosolutions Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow Emergent Biosolutions receives NYSE notice regarding delayed form 10-Q filing Emergent Biosolutions Q3 2023 Earnings Preview For further detail...

GAITHERSBURG, Md., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response at the United States Department of Health and Human...

2023-11-25 16:32:53 ET More on BioCryst Pharmaceuticals, Crinetics Pharmaceuticals, etc. Mirum Pharmaceuticals, Inc. (MIRM) Q3 2023 Earnings Call Transcript BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2023 Earnings Call Transcript Immunocore: First Half Of 2024 IMC-F106...

2023-11-24 07:49:06 ET More on Emergent Biosolutions Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow Emergent BioSolutions Inc. 2023 Q3 - Results - Earnings Call Presentation Emergent BioSolutions Inc. (EBS) Q3 2023 Earnings Call Transcript Eme...

GAITHERSBURG, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today confirmed that on November 16, 2023, the New York Stock Exchange (NYSE) sent a notice that the company is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in fi...

2023-11-23 08:10:13 ET Summary Emergent BioSolutions produces NARCAN nasal spray, traveler's package vaccines and other vaccines periodically stockpiled by the government. NARCAN is experiencing substantial growth due to demand from the opioid epidemic and has received OTC approva...